ATE254628T1 - Meiose regulierende verbindungen. - Google Patents

Meiose regulierende verbindungen.

Info

Publication number
ATE254628T1
ATE254628T1 AT96918629T AT96918629T ATE254628T1 AT E254628 T1 ATE254628 T1 AT E254628T1 AT 96918629 T AT96918629 T AT 96918629T AT 96918629 T AT96918629 T AT 96918629T AT E254628 T1 ATE254628 T1 AT E254628T1
Authority
AT
Austria
Prior art keywords
meiosis regulating
regulating connections
connections
meiosis
regulating
Prior art date
Application number
AT96918629T
Other languages
English (en)
Inventor
Frederik Christian Groenvald
Peter Faarup
Erling Guddal
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE254628T1 publication Critical patent/ATE254628T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0016Oximes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT96918629T 1995-06-23 1996-06-21 Meiose regulierende verbindungen. ATE254628T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK72895 1995-06-23
DK73095 1995-06-23
DK146195 1995-12-22
PCT/DK1996/000273 WO1997000884A1 (en) 1995-06-23 1996-06-21 Meiosis regulating compounds

Publications (1)

Publication Number Publication Date
ATE254628T1 true ATE254628T1 (de) 2003-12-15

Family

ID=27220892

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918629T ATE254628T1 (de) 1995-06-23 1996-06-21 Meiose regulierende verbindungen.

Country Status (18)

Country Link
EP (1) EP0857173B1 (de)
JP (1) JPH11507929A (de)
KR (1) KR19990028366A (de)
CN (1) CN1191543A (de)
AR (1) AR003441A1 (de)
AT (1) ATE254628T1 (de)
AU (1) AU718246B2 (de)
BR (1) BR9608968A (de)
CA (1) CA2224866A1 (de)
CZ (1) CZ408097A3 (de)
DE (1) DE69630802T2 (de)
HU (1) HUP9900454A3 (de)
IL (1) IL122609A0 (de)
NO (1) NO314231B1 (de)
PL (1) PL185622B1 (de)
RU (1) RU2182909C2 (de)
TW (1) TW474943B (de)
WO (1) WO1997000884A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0984980T3 (da) 1997-05-16 2003-03-17 Akzo Nobel Nv 20-aralkyl-5alfa-pregnan-derivater
US6262282B1 (en) * 1997-06-04 2001-07-17 Akzo Nobel N.V. 17β-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
WO1999032506A1 (en) * 1997-12-18 1999-07-01 Akzo Nobel N.V. 17β-ARYL (ARYLMETHYL) OXY(THIO)ALKYL -ANDROSTANE DERIVATIVES
IL139241A0 (en) 1998-05-13 2001-11-25 Novo Nordisk As Meiosis regulating compounds
EP0957108A1 (de) * 1998-05-14 1999-11-17 Schering Aktiengesellschaft Ungesättigte Cholestan-derivate zur Regulierung von Meiose und pharmazeutische Präparate davon
CA2335329A1 (en) * 1998-06-19 1999-12-29 Novo Nordisk A/S Meiosis regulating compounds
JP2002532511A (ja) 1998-12-11 2002-10-02 アクゾ・ノベル・エヌ・ベー 減数分裂調節活性を有する22s−ヒドロキシコレスタ−8,14−ジエン誘導体
WO2000036132A1 (en) * 1998-12-14 2000-06-22 Merck & Co., Inc. Hiv integrase inhibitors
PL350557A1 (en) * 1999-02-10 2002-12-16 Schering Ag Unsaturated cholestane derivatives and their use for the preparation of meiosis regulating medicaments
JP2002537348A (ja) * 1999-02-24 2002-11-05 ノボ ノルディスク アクティーゼルスカブ 不妊症の治療
AU2794100A (en) 1999-02-24 2000-09-14 Novo Nordisk A/S Treatment of infertility
KR100757909B1 (ko) 1999-09-16 2007-09-11 노보 노르디스크 에이/에스 Ivf를 위한 조성물
EP1127890A1 (de) 2000-02-22 2001-08-29 Schering Aktiengesellschaft Steroid Derivate mit einem an Ring A des Steroidgerüstes kondensierten Ring zur Regulierung der Meiose
US20030153808A1 (en) * 2000-02-25 2003-08-14 Christa Hegele-Hartung Implantation rate using ff-mas
EP1245572A1 (de) 2001-03-26 2002-10-02 Schering Aktiengesellschaft Aminosterol-Verbindungen, ihre Verwendung zur Herstellung Meiose-regulierender Medikamenten und ein Vefahren zu ihrer Herstellung
US8399441B2 (en) 2004-10-25 2013-03-19 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis
WO2006047022A1 (en) 2004-10-25 2006-05-04 Virginia Commonwealth University Nuclear sulfated oxysterol, potent regulator of cholesterol homeostasis, for therapy of hypercholesterolemia, hyperlipidemia, and atherosclerosis
CN102258004B (zh) * 2010-05-27 2013-07-17 中国科学院动物研究所 一种体外保存/培养卵母细胞以抑制卵母细胞生发泡破裂的方法
US9034859B2 (en) 2011-04-06 2015-05-19 Virginia Commonwealth University Sulfated oxysterol and oxysterol sulfation by hydroxysterol sulfotransferase promote lipid homeostasis and liver proliferation
US20150158903A1 (en) 2011-09-08 2015-06-11 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
PT3461834T (pt) 2013-03-13 2021-09-10 Sage Therapeutics Inc Esteroides neuroativos
MX2016008459A (es) 2013-12-24 2016-10-14 Univ Virginia Commonwealth Usos de sulfatos de colesterol oxigenados (soc).
JP6628745B2 (ja) 2014-06-18 2020-01-15 セージ セラピューティクス, インコーポレイテッド オキシステロールおよびその使用方法
EA024619B1 (ru) * 2014-11-21 2016-10-31 Эльвин Гаджи оглы Керимли ФРАКСИНОСТЕРИН - 24β-ЭТИЛХОЛЕСТА-20-КАРБОКСИ-6(7),8(9)-ДИЕН 3β-ОЛА И ЕГО ПРОИЗВОДНОЕ
CN108135911B (zh) 2015-07-06 2021-06-25 萨奇治疗股份有限公司 氧甾醇及其使用方法
JP6882996B2 (ja) 2015-07-06 2021-06-02 セージ セラピューティクス, インコーポレイテッド オキシステロールおよびそれらの使用の方法
ES2921010T3 (es) 2016-04-01 2022-08-16 Sage Therapeutics Inc Oxisteroles y procedimientos de uso de los mismos
WO2017193046A1 (en) 2016-05-06 2017-11-09 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
PL3481846T3 (pl) 2016-07-07 2021-12-20 Sage Therapeutics, Inc. 11-podstawione 24-hydroksysterole do stosowania w leczeniu stanów związanych z NMDA
PT3494125T (pt) 2016-08-02 2022-07-07 Durect Corp Composições compreendendo 5-colesten-3, 25-diol, 3-sulfato (25hc3s), ou seu sal farmaceuticamente aceitável, e, pelo menos, um oligossacárido cíclico
US11149056B2 (en) 2016-09-30 2021-10-19 Sage Therapeutics, Inc. C7 substituted oxysterols and methods of use thereof
JP2019532079A (ja) 2016-10-18 2019-11-07 セージ セラピューティクス, インコーポレイテッド オキシステロールおよびその使用方法
US11149054B2 (en) 2016-10-18 2021-10-19 Sage Therapeutics, Inc. Oxysterols and methods of use thereof
CN112430251A (zh) * 2020-11-23 2021-03-02 广州瀚信通信科技股份有限公司 一种治疗白内障的化合物及其制备方法和应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716777A (en) * 1994-06-23 1998-02-10 Novo Nordisk A/S Regulation of meiosis using sterols

Also Published As

Publication number Publication date
TW474943B (en) 2002-02-01
AU6122796A (en) 1997-01-22
IL122609A0 (en) 1998-08-16
CA2224866A1 (en) 1997-01-09
HUP9900454A2 (hu) 1999-06-28
MX9800123A (es) 1998-03-29
NO314231B1 (no) 2003-02-17
KR19990028366A (ko) 1999-04-15
NO976044L (no) 1998-02-20
PL324219A1 (en) 1998-05-11
DE69630802D1 (de) 2003-12-24
CZ408097A3 (cs) 1998-06-17
JPH11507929A (ja) 1999-07-13
DE69630802T2 (de) 2004-08-12
PL185622B1 (pl) 2003-06-30
EP0857173B1 (de) 2003-11-19
CN1191543A (zh) 1998-08-26
HUP9900454A3 (en) 1999-11-29
AU718246B2 (en) 2000-04-13
NO976044D0 (no) 1997-12-22
BR9608968A (pt) 1999-06-29
RU2182909C2 (ru) 2002-05-27
EP0857173A1 (de) 1998-08-12
AR003441A1 (es) 1998-08-05
WO1997000884A1 (en) 1997-01-09

Similar Documents

Publication Publication Date Title
ATE254628T1 (de) Meiose regulierende verbindungen.
TR199501724A2 (tr) Sizdirmazlik saglayici düzen.
DE69636353D1 (de) Datenübetragungsvorrichtung.
BR9612944B8 (pt) Para-herquamidas antiparasíticas.
NL1004863A1 (nl) 5-Amino-4-ethylsulfinyl-1-arylpyrazolen.
SV1996000005A (es) Quinazolinonas bisustituidas en 2,8
NL1002387C2 (nl) Elektrodepositie-apparaat.
NL1000095C2 (nl) Rolhor.
ES1034944Y (es) "distribuidor de tabletas."
NL1000487C2 (nl) Oogstmachine.
TR199600656A2 (tr) Piperidinilmetiloksazolidinonlar.
DE69607150T2 (de) Verbindungen von verteilerkanälen
NL1000773A1 (nl) Funderingssysteem.
IT1276501B1 (it) Via tranviaria.
ITTS950011U1 (it) R.v.t.c.
TR199501236A2 (tr) Halka bicimindeki birarada tutma vasitasi.
KR970045904U (ko) 엘. 씨. 디 콘트라스트 조절장치
ES1031606Y (es) Estuche.
ES1031424Y (es) Estuche.
DE69625708T2 (de) Uv-absorbierende verbindungen
ES1031132Y (es) Prensa-latas.
IT240242Y1 (it) Pentola-colapasta-zuppiera.
ES1031849Y (es) Tapon-grifo.
ES1032657Y (es) Banderilla.
ES1033612Y (es) Octocarton.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties